Surgical Management of Traumatic Bone Cyst Utilizing the Progressive Platelet-rich Fibrin Protocol

Traumatic Bone Cyst (TBC) is a rare and asymptomatic intraosseous lesion, often classified as a pseudocyst, affecting the jaws and long bones. Known by various names such as solitary bone cyst, hemorrhagic bone cyst, simple bone cyst, extravasation cyst, or progressive bone cyst, TBC’s etiopathogenesis remains elusive due to its diverse presentations. The standard treatment protocol for TBC involves surgical excision followed by curettage of the cystic cavity. This surgical intervention induces bleeding, leading to the formation of a blood clot within the cavity, which subsequently promotes the resolution of the lesion and regeneration of new bone. In this context, the use of third-generation Platelet-rich Fibrin (PRF) has emerged as a promising adjunctive therapy to enhance and accelerate the healing process of surgical wounds. PRF, a biomaterial derived from the patient’s own blood, is known for its ability to release growth factors that facilitate tissue regeneration and wound healing. This case report aims to present the surgical removal of a traumatic bone cyst in the anterior mandible of a pediatric patient, highlighting the efficacy of PRF in improving wound healing outcomes. Through this report, we seek to demonstrate the potential benefits of incorporating PRF into the surgical management of TBC, particularly in pediatric patients, to achieve faster and more effective healing.